Alnylam Pharmaceuticals, Inc. (ALNY) Executive Team
Alnylam Pharmaceuticals executive team at a glance
Alnylam Pharmaceuticals lists 10 executives, led by Yvonne L. Greenstreet M.B.A., M.D., CEO & Director (age 62). Jeffrey V. Poulton M.B.A. is the company's CFO & Executive VP (age 57).
In fiscal year 2025 the highest-paid executive was Yvonne L. Greenstreet M.B.A., M.D., CEO & Director, with total pay of $4.99 million. The 7 executives with reported pay received $12.18 million in all.
The average age of the executives with a known age is 60; the youngest is 52 and the oldest 80.
Titles, ages and pay from company filings; pay for fiscal year 2025.
Alnylam Pharmaceuticals, Inc.
Executive Team
Dr. Yvonne L. Greenstreet M.B.A., M.D.
CEO & Director
Dr. Phillip A. Sharp Ph.D.
Co-Founder, Member of the Scientific Advisory Board
Mr. Jeffrey V. Poulton M.B.A.
CFO & Executive VP
Mr. Bryan Andrew Supran J.D.
Chief Legal Officer
Dr. Pushkal P. Garg M.D.
Executive VP & Chief Research & Development Officer
Mr. Tolga Tanguler M.B.A.
Executive VP & Chief Commercialization Officer
Mr. Timothy J. Maines
Chief Technical Operations & Quality Officer
Dr. Kevin Joseph Fitzgerald Ph.D.
Executive VP, Chief Scientific Officer and Head of Early Research & Early Development
Mr. Joshua Brodsky
Vice President of Investor Relations
Mr. Piyush Sharma J.D.
Chief Ethics & Compliance Officer
Alnylam Pharmaceuticals executive pay, fiscal year 2025
| Executive | Title | Age | Total pay |
|---|---|---|---|
| Yvonne L. Greenstreet M.B.A., M.D. | CEO & Director | 62 | $4.99 million |
| Pushkal P. Garg M.D. | Executive VP & Chief Research & Development Officer | 57 | $1.86 million |
| Jeffrey V. Poulton M.B.A. | CFO & Executive VP | 57 | $1.70 million |
| Tolga Tanguler M.B.A. | Executive VP & Chief Commercialization Officer | 52 | $1.50 million |
| Kevin Joseph Fitzgerald Ph.D. | Executive VP, Chief Scientific Officer and Head of Early Research & Early Development | 57 | $1.23 million |
| Bryan Andrew Supran J.D. | Chief Legal Officer | 55 | $845,920 |
| Phillip A. Sharp Ph.D. | Co-Founder, Member of the Scientific Advisory Board | 80 | $52,930 |
Total pay as reported for the fiscal year; it can include salary, bonus and stock awards.
Questions and answers
Who is the CEO of Alnylam Pharmaceuticals?
Yvonne L. Greenstreet M.B.A., M.D. (CEO & Director), age 62; total pay in fiscal year 2025 was $4.99 million.
Who is Alnylam Pharmaceuticals's chief financial officer?
Jeffrey V. Poulton M.B.A. (CFO & Executive VP), age 57.
Who is the highest-paid executive at Alnylam Pharmaceuticals?
Yvonne L. Greenstreet M.B.A., M.D., CEO & Director, with total pay of $4.99 million in fiscal year 2025.
Who are Alnylam Pharmaceuticals's top executives?
Yvonne L. Greenstreet M.B.A., M.D. (CEO & Director), Phillip A. Sharp Ph.D. (Co-Founder, Member of the Scientific Advisory Board), Jeffrey V. Poulton M.B.A. (CFO & Executive VP), Bryan Andrew Supran J.D. (Chief Legal Officer) and Pushkal P. Garg M.D. (Executive VP & Chief Research & Development Officer), and 5 more.
